1 / 15

Global Pharmaceutical Perspective

Global Pharmaceutical Perspective. Daniel VIAL Vicepresidente IMS Europe Milano - 21 settembre 2007. Global pharmaceutical sales 643 billions US $ in 06. % constant US $ growth. Billions US $. Source: IMS Health, IMS Market Prognosis International, Feb 2007. Europe. Size: $ 182 bn

baby
Download Presentation

Global Pharmaceutical Perspective

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Pharmaceutical Perspective Daniel VIAL Vicepresidente IMS Europe Milano - 21 settembre 2007

  2. Global pharmaceutical sales643 billions US$in 06 % constant US $ growth Billions US $ Source: IMS Health, IMS Market Prognosis International, Feb 2007 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 2

  3. Europe Size: $ 182 bn % Growth: 4.8% North America Japan Size: $ 290 bn % Growth: 8% Size: $ 57 bn % Growth: -0.7% Asia/Africa/Australia Size: $ 52 bn % Growth: 9.8% Latin America Size:$ 27.5 bn % Growth: 12.9% 2006: market dynamic is different accordingto the region Source: IMS Health - Global Pharma Forecasts, March 2007 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 3

  4. +2.3% Italy 15.3 bn $ +4% France 26.3 bn $ +0.5% Germany 28.5 bn $ +2.6% Top 5 Europe 98.3 bn $ + 6.3% Spain 11.9 bn $ +3.1% UK 16.3 bn $ 2006: within the region, market dynamic is different according to the country Source : IMS Health – MIDAS – Retail market * : Constant dollar Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 4

  5. Contribution to growthEmerging market contribute to 27% of the total growth 2001 +25.5 Billions US $ 2006 +42.4 Billions US $ % CONTRIBUTION Source: IMS Health, IMS Market Prognosis International, Feb 2007 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 5

  6. 105 44 Number of Global BlockbustersFor the first time, “specialist driven” drugs represent half of the blockbusters 49% Number of Blockbusters 25% 51% 75% Source: IMS Health, MIDAS, MAT Dec 2006, Market Insights Team research Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 6

  7. Protection status in 5 key markets 7 14 11 11 4 7 17 6 12 12 -2 -28 10 -9 -22 -22 -20 -15 14 15 9 11 13 16 Source: IMS Health, MIDAS, New Market Segmentation, RX only, MAT Dec 2006 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 7

  8. Italian retail market: reimbursable drugsSince the 2nd semester 06, a regular decrease of the growth for the units and a negative growth in value* 10.3% 5.9% 4.7% 2.7% - 3.4% -9% *: in public price Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 8

  9. Italian retail market: reimbursable drugsIn units, the reimbursable market is becoming flat Units Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 9

  10. Top 5 Europe: + 2% (1st 07 vs 1st 06) Italian retail market: reimbursable drugsIn value*, the reimbursable market is declining In € -9% *: in public price Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 10

  11. Italian pharma R&D Growth of pharma R&D investment is higher than the restof the industry during the last 6 years R&D investment - in million € + 24.7% + 18.9% Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 11

  12. Italian pharma R&D% of workers in the R&D In % of total employees Rate of workers in pharma R&D is much more higher than in the industry Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 12

  13. 750 Italy 1217 France 1659 Germany 465 Spain 2871 UK R&D : drugs in active development Belgium: 401 - Poland : 155 Source : IMS Health – R&D Focus Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 13

  14. 10 countries: +80% of drugs’ consumption (in value) Top 10 market rankings to 2010China just behind the old Europe 2002 2010 • Italy will be the 6th country in term of drugs’ consumption (in value) • Chinawill be the 7st country in term of drugs’ consumption (in value) • Turkey, South Korea and India will be closed to Top 10 Source: IMS Health -IMS Market Prognosis 2002-2010 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 14

  15. Thank you very much for your attention …. Daniel VIAL Vicepresidente IMS Europe dvial@fr.imshealth.com

More Related